Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis

NCT06342466 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Systemic Amyloidosis

Interventions

DRUG: Bortezomib
DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

Jin Lu, MD